|
Covidien plc News Release
|
A Collection of Covidien plc News Release
|
-
Covidien to Present at BMO Capital Markets Conference
MANSFIELD, Mass., Jul 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products,
will present at the BMO Capital Markets 10th Annual Focus on Healthcare
Conference in New York on Thursday, August 5, 2010. José (Joe) Almeida,
President, Medical Devices, will represent the company in a session
scheduled at 3:30 p.m. ET.
A live audio webcast of the presentation can be accessed at Covidien's
Investor Relations website: http://investor.covidien.com.
An archived edition of the presentation will be available following the
live webcast.
ABOUT COVIDIEN
Covidien is a leading global healthcare produ...
-
Covidien Reports Third-Quarter 2010 Results
Net sales up 2%; Medical Devices sales up 6%
Diluted GAAP earnings per share from continuing operations were $0.70; excluding specified items, adjusted diluted earnings per share from continuing operations were $0.85, up 15%
View PDF
DUBLIN, Jul 29, 2010 (BUSINESS WIRE) --
Covidien plc (NYSE: COV) today reported results for the third quarter of fiscal 2010 (April - June 2010). Third-quarter net sales of $2.56 billion increased 2% from the $2.52 billion reported a year ago, with foreign exchange rate movement having no impact on the quarterly sales growth rate.
Third-quarter 2010 gross margin of 55.6% rose 1.2 percentage points from the 54.4% of the prior-year period. This im...
-
Covidien Completes Acquisition of Somanetics Corporation
DUBLIN, Jul 28, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced that it has completed the previously announced
acquisition of Somanetics Corporation for an aggregate consideration of
approximately $250 million, net of cash and short-term investments
acquired.
Pursuant to the terms of the merger agreement, Covidien DE Corp., an
indirect wholly-owned subsidiary of Covidien, exercised its option to
purchase newly issued shares from Somanetics at the tender offer price
of $25.00 per share. Following the purchase, Covidien DE Corp. owned
sufficient shares to effect a...
-
Covidien Completes Tender Offer for Shares of Somanetics Corporation
DUBLIN, Jul 27, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products,
today announced the completion of its tender offer through its
subsidiary, Covidien DE Corp., to purchase all of the outstanding common
shares of Somanetics Corporation. The tender offer expired at 12:01AM
ET, on July 27, 2010, and was not extended.
The depositary for the tender offer has advised Covidien that, as of the
expiration of the offering period, a total of approximately 9,583,628
common shares of Somanetics were validly tendered and not withdrawn (not
including approximately 581,060 shares subject to guaranteed d...
-
Covidien Declares Quarterly Cash Dividend
DUBLIN, Jul 21, 2010 (BUSINESS WIRE) --Covidien plc (NYSE: COV) today announced that its Board of Directors has
declared a quarterly cash dividend of $0.18 per ordinary share. The
dividend is payable on August 20, 2010, to shareholders of record on
August 2, 2010.
ABOUT COVIDIEN
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers
value through clinical leadership and excellence. Covidien manufactures,
distributes and services a diverse range of industry-leading product
lines in three segments: Medical Devices, Pharmaceuticals and Medical
...
|
